Preventive Medicine, Public Health & General Preventive Medicine · Rancho Cucamonga, CA
NPI
1174937825
Since 2014
Specialty
Preventive Medicine, Public Health & General Preventive Medicine
Code 2083P0901X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8263 Grove Ave Ste 201
Rancho Cucamonga, CA, 91730
Phone (909) 579-0708
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
367 services
Medicare patients, 2024
50
Average age 61
Drug cost, 2024
$4.4M
3,861 prescriptions
Company payments, 2025
$444
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wollelaw W Agmas was code 99213 (office e&m - established), 108 times for 43 patients. In total Wollelaw W Agmas billed 367 services in 16 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 108 | 43 | $52.55 | $5,676 |
| 36415 Venipuncture Blood Collection | Office | 81 | 42 | $8.65 | $701 |
| G0008 Administration of influenza virus vaccine | Office | 15 | 14 | $29.40 | $441 |
By year: 2023 $12K for 234 services; 2024 $14K for 367 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 81 | 42 | $8.65 | $701 |
Medicare prescription drug claims, 2024
In 2024, the drug Wollelaw W Agmas prescribed most often to Medicare patients was Atorvastatin Calcium, with 333 prescriptions and refills. In total Wollelaw W Agmas wrote 3,861 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 333 | 359 | 34 | $950 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 319 | 327 | 35 | $1.2M |
| Lisinopril Generic | 210 | 212 | 22 | $377 |
| Gabapentin Generic | 182 | 182 | 20 | $1,784 |
| Dovato Dolutegravir Sodium/Lamivudine | 140 | 140 | 12 | $399K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 136 | 136 | 13 | $609K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 106 | 106 | 12 | $398K |
| Juluca Dolutegravir/Rilpivirine | 92 | 98 | Under 11 | $327K |
| Prezcobix Darunavir/Cobicistat | 84 | 84 | Under 11 | $201K |
| Metformin Hcl Generic | 84 | 91 | Under 11 | $235 |
| Tamsulosin Hcl Generic | 80 | 80 | Under 11 | $385 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 79 | 79 | Under 11 | $2,568 |
| Omeprazole Generic | 78 | 78 | Under 11 | $169 |
| Tivicay Dolutegravir Sodium | 78 | 78 | Under 11 | $165K |
| Descovy Emtricitabine/Tenofov Alafenam | 72 | 72 | Under 11 | $151K |
Brand drugs: - claims; generic drugs: 2,485 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wollelaw W Agmas $444 ($444 in general payments such as food, travel and fees) from 4 companies. The largest payer was ViiV Healthcare Company with $247.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.